ArticleBMC public health2026
Development and internal validation of a frailty prediction model in adults aged ≥ 45 years with obesity: evidence from the China Health and Retirement Longitudinal Study (CHARLS).
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveGiven the increased risk of frailty among middle-aged and older adults with obesity, we aimed to develop and validate a predictive model for incident frailty among adults aged ≥ 45 years with obesity.
methodsWe used data from the China Health and Retirement Longitudinal Study (CHARLS). Adults aged ≥ 45 years with obesity who were non-frail in 2013 were enrolled as the baseline cohort and followed through 2018. We conducted a complete-case analysis, excluding participants with missing data. Candidate predictors were screened using least absolute shrinkage and selection operator (LASSO) regression and then entered into multivariable logistic regression to build the model. A nomogram was created to facilitate clinical use. Model performance was evaluated by calibration plots, receiver operating characteristic (ROC) curves with the area under the curve (AUC), the Hosmer–Lemeshow goodness-of-fit test, and decision curve analysis (DCA).
resultsA total of 497 participants completed five-year follow-up, of whom 182 developed frailty. Age, alcohol consumption, diabetes, and grip strength were independently associated with incident frailty and were incorporated into the nomogram. The model showed good discrimination (AUC = 0.744, 95% CI: 0.668–0.800) and acceptable calibration by the Hosmer–Lemeshow test, and DCA suggested meaningful net clinical benefit across a range of threshold probabilities.
conclusionsWe developed a simple nomogram to predict 5-year frailty risk among adults aged ≥ 45 years with obesity. The model showed moderate discrimination and acceptable calibration in internal validation, suggesting potential utility for risk stratification pending external validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.